{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:48:50Z","timestamp":1787867330551,"version":"build-2784847793"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.brainresbull.2024.111007","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T20:32:53Z","timestamp":1718224373000},"page":"111007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Involvement of the TRPV1 receptor and the endocannabinoid system in schizophrenia"],"prefix":"10.1016","volume":"215","author":[{"given":"Junjie","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moyin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2024.111007_bib1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.schres.2014.01.039","article-title":"Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: the SHR strain","volume":"153","author":"Almeida","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainresbull.2024.111007_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neuropharm.2019.05.015","article-title":"Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing\/cognitive deficit","volume":"155","author":"Almeida","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainresbull.2024.111007_bib3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1471-4159.2007.04582.x","article-title":"Capsaicin-induced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation","volume":"102","author":"Amantini","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2024.111007_bib4","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1017\/S0033291719001946","article-title":"Childhood trauma and being at-risk for psychosis are associated with higher peripheral endocannabinoids","volume":"50","author":"Appiah-Kusi","year":"2020","journal-title":"Psychol. Med."},{"key":"10.1016\/j.brainresbull.2024.111007_bib5","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/s41467-021-20946-6","article-title":"Anti-inflammatory dopamine- and serotonin-based endocannabinoid epoxides reciprocally regulate cannabinoid receptors and the TRPV1 channel","volume":"12","author":"Arnold","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.brainresbull.2024.111007_bib6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1601-5215.2007.00193.x","article-title":"Pain perception in patients with bipolar disorder and schizophrenia","volume":"19","author":"Atik","year":"2007","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.brainresbull.2024.111007_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neubiorev.2020.06.004","article-title":"Pathophysiology of negative symptom dimensions of schizophrenia - current developments and implications for treatment","volume":"116","author":"Begue","year":"2020","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.brainresbull.2024.111007_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jpsychires.2016.01.002","article-title":"Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis","volume":"75","author":"Bioque","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.brainresbull.2024.111007_bib9","first-page":"646","article-title":"The cannabinoid CB1 receptor in schizophrenia","volume":"6","author":"Borgan","year":"2021","journal-title":"Biol. Psychiatry.: Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.brainresbull.2024.111007_bib10","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.bbadis.2007.05.003","article-title":"TRP\u2019s: links to schizophrenia?","volume":"1772","author":"Chahl","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.brainresbull.2024.111007_bib11","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/schbul\/sby058","article-title":"Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016","volume":"44","author":"Charlson","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.brainresbull.2024.111007_bib12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.psychres.2016.08.055","article-title":"Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia","volume":"245","author":"Chase","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.brainresbull.2024.111007_bib13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.schres.2010.07.029","article-title":"Psychophysiological prodromal signs of schizophrenic relapse: a pilot study","volume":"123","author":"Dawson","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainresbull.2024.111007_bib14","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1523\/JNEUROSCI.1100-19.2019","article-title":"Cell-type- and endocannabinoid-specific synapse connectivity in the adult nucleus accumbens core","volume":"40","author":"Deroche","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2024.111007_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fpsyt.2012.00085","article-title":"Plasma endocannabinoid alterations in individuals with substance use disorder are dependent on the \u201cMirror Effect\u201d of schizophrenia","volume":"3","author":"Desfosses","year":"2012","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.brainresbull.2024.111007_bib16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nn1457","article-title":"Endocannabinoid control of food intake and energy balance","volume":"8","author":"Di Marzo","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainresbull.2024.111007_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112734","article-title":"Red-hot chili receptors: a systematic review of TRPV1 antagonism in animal models of psychiatric disorders and addiction","volume":"393","author":"Escelsior","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2024.111007_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/jamapsychiatry.2019.2968","article-title":"Reflections on the link between income during childhood and risk of developing schizophrenia","volume":"77","author":"Frank","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.brainresbull.2024.111007_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12016-020-08824-3","article-title":"New insights on the role of TRP channels in calcium signalling and immunomodulation: review of pathways and implications for clinical practice","volume":"60","author":"Froghi","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.brainresbull.2024.111007_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110096","article-title":"Endocannabinoid system in psychotic and mood disorders, a review of human studies","volume":"106","author":"Garani","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2024.111007_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/npp.2017.130","article-title":"Circulating endocannabinoids: from whence do they come and where are they going?","volume":"43","author":"Hillard","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2024.111007_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroscience.2011.11.020","article-title":"Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence","volume":"204","author":"Hillard","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2024.111007_bib23","first-page":"1","article-title":"Endocannabinoid signaling and the hypothalamic-pituitary-adrenal axis","author":"Hillard","year":"2016","journal-title":"Compr. Physiol. 7"},{"key":"10.1016\/j.brainresbull.2024.111007_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bcp.2018.07.009","article-title":"The endocannabinoid system in mental disorders: evidence from human brain studies","volume":"157","author":"Ibarra-Lecue","year":"2018","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.brainresbull.2024.111007_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/apha.12474","article-title":"Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells","volume":"214","author":"Jean-Gilles","year":"2015","journal-title":"Acta Physiol. (Oxf. )"},{"key":"10.1016\/j.brainresbull.2024.111007_bib26","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/ejn.15509","article-title":"Plasmatic endocannabinoids are decreased in subjects with ultra-high risk of psychosis","volume":"55","author":"Joaquim","year":"2022","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainresbull.2024.111007_bib27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.brainresbull.2024.111007_bib28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1192\/bjp.bp.108.053843","article-title":"Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis","volume":"194","author":"Koethe","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.brainresbull.2024.111007_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/15622975.2018.1449966","article-title":"Familial abnormalities of endocannabinoid signaling in schizophrenia","volume":"20","author":"Koethe","year":"2019","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2024.111007_bib30","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.bbi.2017.03.007","article-title":"Modulation of neuroinflammation: role and therapeutic potential of TRPV1 in the neuro-immune axis","volume":"64","author":"Kong","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainresbull.2024.111007_bib31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/appi.ajp.2019.19010034","article-title":"Dose-response meta-analysis of antipsychotic drugs for acute schizophrenia","volume":"177","author":"Leucht","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainresbull.2024.111007_bib32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s40263-018-0539-z","article-title":"Role of the endocannabinoid system in the pathophysiology of schizophrenia: implications for pharmacological intervention","volume":"32","author":"Leweke","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.brainresbull.2024.111007_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.31887\/DCNS.2020.22.3\/blutz","article-title":"Neurobiology of cannabinoid receptor signaling","volume":"22","author":"Lutz","year":"2020","journal-title":"Dialog-. Clin. Neurosci."},{"key":"10.1016\/j.brainresbull.2024.111007_bib34","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/ATVBAHA.113.303346","article-title":"Nicotinic acid activates the capsaicin receptor TRPV1: potential mechanism for cutaneous flushing","volume":"34","author":"Ma","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.brainresbull.2024.111007_bib35","first-page":"80","article-title":"Supraspinal transient receptor potential subfamily V member 1 (TRPV1) in pain and psychiatric disorders","author":"Madasu","year":"2015","journal-title":"Mod. Trends Pharm. 30"},{"key":"10.1016\/j.brainresbull.2024.111007_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.schres.2013.04.026","article-title":"Schizoaffective disorder in the DSM-5","volume":"150","author":"Malaspina","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainresbull.2024.111007_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","article-title":"The endocannabinoid system and the brain","volume":"64","author":"Mechoulam","year":"2013","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.brainresbull.2024.111007_bib38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bcp.2018.08.037","article-title":"Gut microbiota, cannabinoid system and neuroimmune interactions: new perspectives in multiple sclerosis","volume":"157","author":"Mestre","year":"2018","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.brainresbull.2024.111007_bib39","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1177\/0269881119857205","article-title":"Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophrenia","volume":"33","author":"Muguruza","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.brainresbull.2024.111007_bib40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/HRP.0000000000000110","article-title":"Electrophysiological endophenotypes for schizophrenia","volume":"24","author":"Owens","year":"2016","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.brainresbull.2024.111007_bib41","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/bph.13392","article-title":"What is the evidence for the role of TRP channels in inflammatory and immune cells?","volume":"173","author":"Parenti","year":"2016","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.brainresbull.2024.111007_bib42","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/15622975.2016.1246750","article-title":"Association of anandamide with altered binocular depth inversion illusion in schizophrenia","volume":"18","author":"Reuter","year":"2017","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2024.111007_bib43","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3389\/fphar.2017.00399","article-title":"Cannabinoids and vanilloids in schizophrenia: neurophysiological evidence and directions for basic research","volume":"8","author":"Ruggiero","year":"2017","journal-title":"Front. Pharm."},{"key":"10.1016\/j.brainresbull.2024.111007_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201700270","article-title":"Proteomics and lipidomics in the elucidation of endocannabinoid signaling in healthy and schizophrenia brains","volume":"18","author":"Seabra","year":"2018","journal-title":"Proteomics"},{"key":"10.1016\/j.brainresbull.2024.111007_bib45","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.0906e11","article-title":"The neurobiology of cognition in schizophrenia","volume":"67","author":"Tamminga","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.brainresbull.2024.111007_bib46","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41398-020-0832-8","article-title":"Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia","volume":"10","author":"Tao","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.brainresbull.2024.111007_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2020.02.167","article-title":"ENIGMA and global neuroscience: a decade of large-scale studies of the brain in health and disease across more than 40 countries","volume":"87","author":"Thompson","year":"2020","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.brainresbull.2024.111007_bib48","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuropharm.2015.12.020","article-title":"Dorsolateral periaqueductal gray matter CB1 and TRPV1 receptors exert opposite modulation on expression of contextual fear conditioning","volume":"103","author":"Uliana","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainresbull.2024.111007_bib49","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.biopsych.2015.06.015","article-title":"The role of endocannabinoid signaling in cortical inhibitory neuron dysfunction in schizophrenia","volume":"79","author":"Volk","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2024.111007_bib50","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jpsychires.2018.04.002","article-title":"Alterations of eicosanoids and related mediators in patients with schizophrenia","volume":"102","author":"Wang","year":"2018","journal-title":"J. Psychiatr. Res"},{"key":"10.1016\/j.brainresbull.2024.111007_bib51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41537-023-00406-4","article-title":"Capsaicin alleviates neuronal apoptosis and schizophrenia-like behavioral abnormalities induced by early life stress","volume":"9","author":"Xu","year":"2023","journal-title":"Schizophr"},{"key":"10.1016\/j.brainresbull.2024.111007_bib52","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/schbul\/sbv130","article-title":"Prevalence and specificity of the abnormal niacin response: a potential endophenotype marker in schizophrenia","volume":"42","author":"Yao","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.brainresbull.2024.111007_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/srep26088","article-title":"TRPV1 is crucial for proinflammatory STAT3 signaling and thermoregulation-associated pathways in the brain during inflammation","volume":"6","author":"Yoshida","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainresbull.2024.111007_bib54","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12264-016-0079-9","article-title":"Altered motor-striatal plasticity and cortical functioning in patients with schizophrenia","volume":"33","author":"Zhou","year":"2017","journal-title":"Neurosci. Bull."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923024001400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923024001400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:19:02Z","timestamp":1729642742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923024001400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":54,"alternative-id":["S0361923024001400"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2024.111007","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of the TRPV1 receptor and the endocannabinoid system in schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2024.111007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111007"}}